A Study to Determine the Safety and the Efficacy of Fasinumab Compared to Placebo and Naproxen for Treatment of Adults With Pain From Osteoarthritis of the Knee or Hip

NCT03161093 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

3307

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoarthritis, Knee
Osteoarthritis, Hip

Interventions

DRUG: Fasinumab
DRUG: Naproxen
DRUG: Fasinumab-matching placebo
DRUG: Naproxen-matching placebo

Sponsor

Regeneron Pharmaceuticals

Collaborators

[object Object]